>Dew and others interested in Imclone. Do any of you know about the Yeda vs. Imclone patent suit… Could this be holding up the sale of Imclone? Lots of volume, no price increase.<
Hi lois. Long time. My short answer is No—this dispute is not holding up a “strategic transaction” involving IMCL nor is it affecting the price of any prospective deal to a material degree. Why do I say this? Because I think the patent in dispute isn’t worth much in the first place. I don’t see how a dispute over something trivial can be non-trivial. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”